Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

CSE:HUGE - Post Discussion

FSD Pharma Inc > FSD Pharma Morningstar Fair Value $3.23 USD
View:
Post by JensLens on Jun 12, 2022 8:18pm

FSD Pharma Morningstar Fair Value $3.23 USD

https://docdro.id/qUAE6ur
Comment by Mil_Man54 on Jun 12, 2022 11:02pm
Cherrypicking again Rosenberg....you forgot the part where "Uncertainty=EXTREME"....gee....wonder why....get off the boards pumper!
Comment by Renofund on Jun 14, 2022 7:54am
now pumping lower target prices haha.  For those who may not be aware, this works out to roughly $0.016 (1.6 cents) pre-split.  Destruction of capital thus far. 
Comment by rad10 on Jun 16, 2022 4:25pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities